Schlegel Andrea, Muller Xavier, Dutkowski Philipp
1The Liver Unit, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
2NIHR Liver Biomedical Research Unit, University Hospitals Birmingham, Birmingham, UK.
Curr Transplant Rep. 2018;5(1):93-102. doi: 10.1007/s40472-018-0183-z. Epub 2018 Jan 22.
In this review, we highlight which livers may benefit from additional treatment before implantation and describe the concept of hypothermic machine liver perfusion. Furthermore, we explain why cold oxygenated perfusion concepts could potentially lead to a breakthrough in this challenging field of transplantation. Accordingly, we summarize recent clinical applications of different hypothermic perfusion approaches.
The impact of end-ischemic, hypothermic liver perfusion in liver transplantation is currently assessed by two multicenter, randomized controlled trials. Recently, new applications of hypothermic perfusion showed promising results and recipients were protected from severe intrahepatic biliary complications, despite the use of very extended criteria grafts including donation after circulatory death livers.
Hypothermic machine liver perfusion is beneficial for high-risk livers and protects recipients from most feared complications. Importantly, such easy approach is currently implemented in several European centers and new markers obtained from perfusate may improve the prediction of liver function in the future.
在本综述中,我们强调哪些肝脏在植入前可能从额外治疗中获益,并描述低温机器肝脏灌注的概念。此外,我们解释了为何冷氧合灌注概念可能会在这个具有挑战性的移植领域带来突破。因此,我们总结了不同低温灌注方法的近期临床应用情况。
目前有两项多中心随机对照试验正在评估缺血后低温肝脏灌注在肝移植中的影响。最近,低温灌注的新应用显示出了有前景的结果,并且尽管使用了包括循环死亡后捐赠肝脏在内的非常宽泛标准的移植物,受者仍免受严重肝内胆管并发症的影响。
低温机器肝脏灌注对高危肝脏有益,并能保护受者免受最可怕的并发症影响。重要的是,这种简便的方法目前已在多个欧洲中心实施,并且从灌注液中获得的新标志物可能会在未来改善对肝功能的预测。